Navigation Links
Gen-Probe Reports Financial Results for Second Quarter 2009
Date:7/30/2009

(3) 2009 and percentage changes include transplant diagnostics and genetic testing product sales associated with the Tepnel acquisition.

(4) 2008 figures exclude revenues associated with the Tepnel acquisition, since Tepnel was not part of Gen-Probe in the prior year period.

                              Gen-Probe Incorporated
                         Consolidated Balance Sheets - GAAP
                    (In thousands, except share and per share data)

                                                        June 30,  December 31,
                                                           2009         2008
                                                           ----         ----
                                                       (unaudited)
    Assets
    Current assets:
       Cash and cash equivalents                       $233,506      $60,122
       Marketable securities                            230,698      371,276
       Trade accounts receivable, net of allowance
        for doubtful accounts of $691 and $700 at
        June 30, 2009 and December 31, 2008,
        respectively                                     39,946       33,397
       Accounts receivable - other                        2,852        2,900
       Inventories                                       56,455       54,406
       Deferred income tax                                9,136        7,269
       Prepaid income tax                                 6,863        2,306
       Prepaid expenses                                  13,388       15,094
       Other current assets                               4,322        6,135
                                                          -----        -----
    Total current assets                                597,166      552,905

    Marketable securities, net of current
     portion                                            105,037       73,780
    Property, plant and e
'/>"/>
SOURCE  Gen-Probe Incorporated
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 

Related medicine news :

1. Gen-Probe to Webcast Two Upcoming Investor Presentations
2. Gen-Probe Reports Financial Results for First Quarter 2009
3. Gen-Probe, Roche Prevail in Arbitration With Digene Concerning Human Papillomavirus Agreement
4. Gen-Probe Board of Directors Elects Carl Hull Chief Executive Officer
5. Tepnel Shareholders Approve Acquisition by Gen-Probe
6. Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2008
7. Gen-Probe to Acquire Tepnel Life Sciences, Fast-Growing European Molecular Diagnostics Company, for 92.8 Million Pounds Sterling ($132.2 Million) in Cash
8. Gen-Probe and Novartis Agree to Extend and Expand Blood Screening Collaboration
9. Eric Tardif Joins Gen-Probe as Senior Vice President, Corporate Strategy
10. Gen-Probe to Webcast Presentation at the 27th Annual J.P. Morgan Healthcare Conference
11. Gen-Probe to Webcast Presentation at the 20th Annual Piper Jaffray Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2010)... drug being developed to treat infections caused by Hepatitis ... the initial phase (phase 1a) of trials of INX-189, ... Welsh School of Pharmacy in 2008, means the chances ... , Approximately 170 million people worldwide are affected ... cirrhosis and death. It is the leading cause of ...
(Date:9/2/2010)... U.S., as part of the Infantile Spasms Working Group ... infantile spasms (IS). The goal of the ... that educate pediatricians on early diagnosis and treatment options. ... Epilepsia , a journal published by Wiley-Blackwell on ... spasmsknown also as West syndrome and named after Dr. ...
(Date:9/2/2010)... Ala. Cigarette smoke shuts off a key enzyme ... according to findings from the University of Alabama at ... , The UAB researchers say smoke inhibits ... to fail in its job of shutting down white ... , The team says the research study ...
(Date:9/2/2010)... , , THURSDAY, Sept. 2 (HealthDay News) -- An experimental ... hours, making only one doctor visit necessary before treatment ... against a disease that kills nearly 2 million people ... is a very important discovery," said infectious disease expert ... New York University. "This could be an important tool ...
(Date:9/2/2010)... 31, 2010 In two closely related studies, two ... underlying mechanisms that activate a type of immune cell ... lead to the development of new therapies to treat ... of the two companion studies were published in the ... Science . Together, the new research sheds light on ...
Breaking Medicine News(10 mins):Health News:First clinical trials successfully completed on potent new hepatitis C drug 2Health News:US neurologists agree on protocols for treatment of infantile spasms 2Health News:US neurologists agree on protocols for treatment of infantile spasms 3Health News:US neurologists agree on protocols for treatment of infantile spasms 4Health News:US neurologists agree on protocols for treatment of infantile spasms 5Health News:Cigarette smoke may contribute to lung inflammation through a new chemical pathway 2Health News:Experimental TB Test Called Fast and Accurate 2Health News:Experimental TB Test Called Fast and Accurate 3Health News:Scientists discover the mechanisms and function of a type of mysterious immune cell 2Health News:Scientists discover the mechanisms and function of a type of mysterious immune cell 3Health News:Scientists discover the mechanisms and function of a type of mysterious immune cell 4Health News:Scientists discover the mechanisms and function of a type of mysterious immune cell 5
... Gerson Lehrman Group, the world,s,leading marketplace for ... community devoted to providing patients with the,medication information ... provides personalized iGuard Risk Ratings, iGuard Safety Alerts,and ... with other registered,users who also want to get ...
... a chief reason that,patients seek medical attention; opioid ... must be able to determine which opioid,treatment will ... To make clinicians aware of the importance of ... Clinical Practice and The,Journal of Family Practice: Special ...
... Treatment could help breast cancer patients and menopausal women, ... An injection of a local anesthetic into the nerves ... cancer patients long-term relief from hot flashes and sleep ... often accompany treatment for breast cancer, especially among women ...
... PRO-DEX, INC. (Nasdaq:,PDEX) invites shareholders and investors to listen ... quarter financial results, and a discussion,of the outlook for ... be broadcast live over the Internet on,Thursday, May 15, ... accessed by,visiting the Company,s website at http://www.pro-dex.com . ...
... for a safer barefoot summer, CHICAGO, May 15 ... suffer injuries such as cuts,and puncture wounds. Some will develop ... protect feet and toes from injury is to wear shoes. ... sand between your toes,or walking in your backyard barefoot, doctors ...
... ... May 15 Meet Cindy Zamirowski, a 56-year-old,breast cancer survivor who less ... stepped off the curb to raise funds for,cancer research in the 5K ... and grandma of three rallied her team of,16 angels at her side ...
Other Medicine News:Health News:Gerson Lehrman Group and iGuard, Inc. Partner to Offer Patients a Voice in Healthcare Industry Decisions 2Health News:Gerson Lehrman Group and iGuard, Inc. Partner to Offer Patients a Voice in Healthcare Industry Decisions 3Health News:Treat Your Patients' Pain Effectively 2Health News:Hot Flashes Reduced by Neck Injection 2Health News:Hot Flashes Reduced by Neck Injection 3Health News:Pro-Dex, Inc. Announces Fiscal 2008 Third Quarter Financial Results Conference Call and Webcast 2Health News:Going barefoot? Beware! 2Health News:After Effects: Giving Back Is Good for You 2
(Date:9/3/2010)... /PRNewswire-Asia-FirstCall/ -- ... ... ... s = ,; var first_result; // Results are keyed by longUrl, so we need to ... for (var key in first_result) { //s += key + ":" + first_result[key].toString() + " ...
(Date:9/3/2010)... Stock... -- JERUSALEM, September 3, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... var shortURL = ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; ... (var r in data.results) { first_result = data.results[r]; break; } for (var key in first_result) ...
(Date:9/3/2010)... -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ... Stanley Global Healthcare Conference on Monday, September 13, ... Eastern Time.  The session may be accessed through ... the Investor Relations page.  An archived version of ... webcast through October 13, 2010.   ...
Breaking Medicine Technology:China Sky One Medical Updates Financial Guidance for 2010 2China Sky One Medical Updates Financial Guidance for 2010 3China Sky One Medical Updates Financial Guidance for 2010 4China Sky One Medical Updates Financial Guidance for 2010 5China Sky One Medical Updates Financial Guidance for 2010 6China Sky One Medical Updates Financial Guidance for 2010 7China Sky One Medical Updates Financial Guidance for 2010 8Medisafe 1 Technologies Clarifies the PR Issued on September 1 for the Stock Dividend, as a Forward Split of 5-1 in the Form of a Stock Dividend 2Medisafe 1 Technologies Clarifies the PR Issued on September 1 for the Stock Dividend, as a Forward Split of 5-1 in the Form of a Stock Dividend 3Medisafe 1 Technologies Clarifies the PR Issued on September 1 for the Stock Dividend, as a Forward Split of 5-1 in the Form of a Stock Dividend 4Medisafe 1 Technologies Clarifies the PR Issued on September 1 for the Stock Dividend, as a Forward Split of 5-1 in the Form of a Stock Dividend 5Medisafe 1 Technologies Clarifies the PR Issued on September 1 for the Stock Dividend, as a Forward Split of 5-1 in the Form of a Stock Dividend 6Medisafe 1 Technologies Clarifies the PR Issued on September 1 for the Stock Dividend, as a Forward Split of 5-1 in the Form of a Stock Dividend 7Unique coral reef education pilot program to be conducted in the Bahamas 13094 1Unique coral reef education pilot program to be conducted in the Bahamas 13094 2New reliable method based on patients gait helps to diagnose fibromyalgia 71112 1New reliable method based on patients gait helps to diagnose fibromyalgia 71112 2Merely seeing disease symptoms may promote aggressive immune response 71109 1Merely seeing disease symptoms may promote aggressive immune response 71109 2
... Study Will Correlate the Results of Rosetta Genomics, ... at M.D. Anderson Cancer Center,Data on the Company,s ... Accuracy was Recently Published in the April Issue ... CITY, New Jersey, August 11, Rosetta Genomics, Ltd. ...
... DIEGO, Aug. 7 Ardea,Biosciences, Inc. (Nasdaq: ... was presented,from its completed Phase 2a proof-of-concept ... non-nucleoside reverse transcriptase,inhibitor (NNRTI) for patients with ... with a well-tolerated profile. An,oral presentation of ...
Other Medicine Technology:M. D. Anderson to Initiate Clinical Validation Study on Rosetta Genomics' MicroRNA-based Diagnostic Assay Identifying the Origin of Cancer Metastases 2M. D. Anderson to Initiate Clinical Validation Study on Rosetta Genomics' MicroRNA-based Diagnostic Assay Identifying the Origin of Cancer Metastases 3M. D. Anderson to Initiate Clinical Validation Study on Rosetta Genomics' MicroRNA-based Diagnostic Assay Identifying the Origin of Cancer Metastases 4Ardea Biosciences Presents Phase 2a Antiviral Activity Data for Lead HIV Candidate, RDEA806 at XVII International AIDS Conference 2Ardea Biosciences Presents Phase 2a Antiviral Activity Data for Lead HIV Candidate, RDEA806 at XVII International AIDS Conference 3Ardea Biosciences Presents Phase 2a Antiviral Activity Data for Lead HIV Candidate, RDEA806 at XVII International AIDS Conference 4
... Codman Sofwire Cable System, ... fixation including sublaminar interspinous ... facial surgery, sternotomy closure. ... and a complete set ...
Demineralized bone matrix dispensed in a jar. Fibers will be free of foreign matter. Glycerol 70-88% by weight. Calcium content less than 8%....
... Inductive demineralized bone matrix and ... cancellous chips will be free ... matrix particle size is 125 ... particle size is 1 - ...
Demineralized Freeze-dried Bone Allograft (DFDBA) processed from cortical bone. Demineralized cortical powder is free of all soft tissue....
Medicine Products: